Published 2021
“…To optimize the period of preprocedural warfarin interruption to
decrease the incidence of bleeding in case of bridging and the incidence of thromboembolism in case of
non-bridging, a study was conducted to determine the influence of CYP2
C9, VKORC1, CYP4F2, FII, and FVII genetic polymorphisms and
non-genetic factors on INR decline in a cohort of Arabs undergoing a procedure that requires warfarin interruption and developing an algorithm to tailor the duration of warfarin interruption before the procedure. …”
Get full text